142 related articles for article (PubMed ID: 1847721)
1. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy.
Holdaas H; Hartmann A; Lien MG; Nilsen L; Jervell J; Fauchald P; Endresen L; Djøseland O; Berg KJ
J Intern Med; 1991 Feb; 229(2):163-70. PubMed ID: 1847721
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
Holdaas H; Hartmann A; Berg KJ; Langberg H; Blystad L; Fauchald P
J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
[TBL] [Abstract][Full Text] [Related]
3. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
[TBL] [Abstract][Full Text] [Related]
5. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
6. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
[TBL] [Abstract][Full Text] [Related]
7. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
[TBL] [Abstract][Full Text] [Related]
8. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
[TBL] [Abstract][Full Text] [Related]
9. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
[TBL] [Abstract][Full Text] [Related]
10. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
Campo C; Garcia-Vallejo O; Barrios V; Lahera V; Manero M; Esteban E; Rodicio JL; Ruilope LM
J Hypertens; 1997 Dec; 15(12 Pt 2):1803-8. PubMed ID: 9488243
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
Widecka K; Celibała R; Czekalski S
Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Parving HH; Rossing P; Hommel E; Smidt UM
Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
[TBL] [Abstract][Full Text] [Related]
13. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption.
Jacobs EM; Vervoort G; Branten AJ; Klasen I; Smits P; Wetzels JF
Eur J Clin Invest; 1999 Feb; 29(2):109-15. PubMed ID: 10092997
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
16. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
[TBL] [Abstract][Full Text] [Related]
17. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
Kamper AL; Holstein-Rathlou NH; Leyssac PP; Strandgaard S
Am J Kidney Dis; 1996 Dec; 28(6):822-31. PubMed ID: 8957033
[TBL] [Abstract][Full Text] [Related]
18. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
[TBL] [Abstract][Full Text] [Related]
19. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
[TBL] [Abstract][Full Text] [Related]
20. Improved renal function during chronic lisinopril treatment in moderate to severe primary hypertension.
Dupont AG; Van der Niepen P; Volckaert A; Ingels M; Bossuyt AM; Jonckheer MH; Six RO
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S148-50. PubMed ID: 2485052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
